We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXT icon
2376
Rackspace Technology
RXT
$1.24B
$2.52M ﹤0.01%
132,185
+32,036
+32% +$578K
CNXN icon
2377
PC Connection
CNXN
$2.12B
$2.51M ﹤0.01%
53,129
+1,991
+4% +$91.5K
CRAI icon
2378
CRA International
CRAI
$1.06B
$2.51M ﹤0.01%
49,226
-34,945
-42% -$1.57M
LXFR icon
2379
Luxfer Holdings
LXFR
$458M
$2.49M ﹤0.01%
151,825
+5,555
+4% +$81.2K
HONE
2380
DELISTED
HarborOne Bancorp
HONE
$2.49M ﹤0.01%
229,035
-8,524
-4% -$84K
XRN
2381
Chiron Real Estate Inc
XRN
$477M
$2.49M ﹤0.01%
38,074
+567
+2% +$39K
PRLD icon
2382
Prelude Therapeutics
PRLD
$390M
$2.48M ﹤0.01%
+34,722
New +$1.73M
KREF
2383
KKR Real Estate Finance Trust
KREF
$499M
$2.48M ﹤0.01%
138,325
+7,952
+6% +$141K
CLDT
2384
Chatham Lodging
CLDT
$586M
$2.48M ﹤0.01%
229,237
-20,400
-8% -$195K
PDFS icon
2385
PDF Solutions
PDFS
$2.07B
$2.47M ﹤0.01%
114,484
-80,728
-41% -$1.69M
NWLI
2386
DELISTED
National Western Life Group, Inc. Class A
NWLI
$2.46M ﹤0.01%
11,902
+254
+2% +$49.3K
PETS icon
2387
PetMed Express
PETS
$42.3M
$2.45M ﹤0.01%
76,558
+228
+0.3% +$7.03K
FFG
2388
DELISTED
FBL Financial Group
FFG
$2.45M ﹤0.01%
46,707
-254
-0.5% -$13.1K
TXMD icon
2389
TherapeuticsMD
TXMD
$24M
$2.44M ﹤0.01%
40,325
+3,403
+9% +$232K
MCFE
2390
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$2.44M ﹤0.01%
+146,107
New +$2.42M
GIC icon
2391
Global Industrial
GIC
$1.49B
$2.42M ﹤0.01%
67,310
+2,846
+4% +$84.9K
KYMR icon
2392
Kymera Therapeutics
KYMR
$8.94B
$2.41M ﹤0.01%
+38,833
New +$1.89M
ICPT
2393
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.4M ﹤0.01%
97,392
-124,393
-56% -$4.12M
IMUX icon
2394
Immunic
IMUX
$195M
$2.4M ﹤0.01%
15,709
-814
-5% -$146K
MOMO
2395
Hello Group
MOMO
$866M
$2.4M ﹤0.01%
171,779
-7,085
-4% -$102K
EGRX
2396
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.4M ﹤0.01%
51,476
+1,795
+4% +$84K
CSTE icon
2397
Caesarstone
CSTE
$79.5M
$2.38M ﹤0.01%
184,919
+423
+0.2% +$4.83K
RUTH
2398
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$2.38M ﹤0.01%
134,310
+20,328
+18% +$286K
PASG icon
2399
Passage Bio
PASG
$14.1M
$2.37M ﹤0.01%
4,643
+651
+16% +$261K
OOMA icon
2400
Ooma
OOMA
$604M
$2.37M ﹤0.01%
164,780
+20,708
+14% +$306K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.